About

Mikhail Chernov is a leading figure in the field of stereotactic radiosurgery, with a particular focus on the development and clinical application of "robotic microradiosurgery" for complex intracranial tumors. His research centers on using advanced computer-aided technologies, such as the Leksell Gamma Knife Model C with its Automatic Positioning System, to achieve precise, high-dose radiation delivery while minimizing damage to surrounding healthy tissue. Chernov’s major contributions include pioneering treatment concepts for pituitary adenomas invading the cavernous sinus (57 citations) and for residual or recurrent craniopharyngiomas (41 citations), demonstrating improved tumor control and functional outcomes. He has also extensively studied the management of benign skull base meningiomas and vestibular schwannomas, with his work on tumor shrinkage correlating with radiation energy density (21 citations) offering a novel dosimetric insight. His cumulative impact is evidenced by over 200 citations across his most-cited works, which have helped establish robotic microradiosurgery as a standard-of-care alternative to microsurgery. More recently, Chernov has expanded into information-guided surgery for gliomas and the use of robotic stereotactic assistance (ROSA) for epilepsy surgery, showcasing his ongoing commitment to integrating cutting-edge technology into neurosurgical practice.

Research Focus

Key Achievements

8
H-Index
13
Papers
253
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Gamma Knife robotic microradiosurgery of pituitary adenomas invading the cavernous sinus: treatment concept and results in 89 cases
57 citations · 2010
📈 Most Prolific Year: 2010 (3 Papers)
🤝 Key Collaborators: 43
🏛 Institutions: Tokyo Women's Medical University, Tokyo Women's Medical University Adachi Medical Center, Saitama Municipal Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago